Clinical Trials

Sponsor: National Cancer Institute

Sponsor Study ID: R01 CA261232-01

Study Title: Optimizing Tobacco Treatment Delivery for People Living with HIV

NCT Number: NCT05019495

Phase: N/A

Protocol Type: Health Services Research

Age Group: Adults

Disease Sites:

Study Objectives: To conduct a randomized clinical trial with PLWH who smoke (N=230) comparing smoking cessation outcomes consistent with the RFA including: biochemically verified 7-day point prevalence abstinence (PPA) rates, continuous abstinence (Weeks 9-12), and the number of 24-hour quit attempts at the end of study treatment (Week 12) between participants who receive TAU and PrOMOTE.



Study Documents    
(MUSC NetID required for document access)